The Use of a Pressure-Indicating Sensor Film to Provide Feedback upon Hydrogel-Forming Microneedle Array Self-Application In Vivo by Vicente-Perez, Eva M. et al.
The Use of a Pressure-Indicating Sensor Film to Provide
Feedback upon Hydrogel-Forming Microneedle Array Self-
Application In Vivo
Vicente-Perez, E. M., Quinn, H. L., McAlister, E., O' Neill, S., Hanna, L-A., Barry, J. G., & Donnelly, R. F. (2016).
The Use of a Pressure-Indicating Sensor Film to Provide Feedback upon Hydrogel-Forming Microneedle Array
Self-Application In Vivo. Pharmaceutical Research. DOI: 10.1007/s11095-016-2032-z
Published in:
Pharmaceutical Research
Document Version:
Publisher's PDF, also known as Version of record
Queen's University Belfast - Research Portal:
Link to publication record in Queen's University Belfast Research Portal
Publisher rights
Copyright The Author(s) 2016. This article is published with open access at SpringerLink.com
This article is distributed under the terms of the Creative Commons Attribution 4.0 International License
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you
give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were
made.
General rights
Copyright for the publications made accessible via the Queen's University Belfast Research Portal is retained by the author(s) and / or other
copyright owners and it is a condition of accessing these publications that users recognise and abide by the legal requirements associated
with these rights.
Take down policy
The Research Portal is Queen's institutional repository that provides access to Queen's research output. Every effort has been made to
ensure that content in the Research Portal does not infringe any person's rights, or applicable UK laws. If you discover content in the
Research Portal that you believe breaches copyright or violates any law, please contact openaccess@qub.ac.uk.
Download date:15. Feb. 2017
RESEARCH PAPER
The Use of a Pressure-Indicating Sensor Film to Provide
Feedback upon Hydrogel-Forming Microneedle
Array Self-Application In Vivo
Eva M. Vicente-Pérez 1 & Helen L. Quinn 1 & Emma McAlister 1 & Shannon O’Neill 1 &
Lezley-Anne Hanna1 & Johanne G. Barry1 & Ryan F. Donnelly1
Received: 8 June 2016 /Accepted: 25 August 2016
# The Author(s) 2016. This article is published with open access at SpringerLink.com
ABSTRACT
Purpose To evaluate the combination of a pressure-
indicating sensor film with hydrogel-forming microneedle ar-
rays, as a method of feedback to confirm MN insertion in vivo.
Methods Pilot in vitro insertion studies were conducted using a
Texture Analyser to insert MN arrays, coupled with a
pressure-indicating sensor film, at varying forces into excised
neonatal porcine skin. In vivo studies involved twenty human
volunteers, who self-applied two hydrogel-forming MN ar-
rays, one with a pressure-indicating sensor film incorporated
and one without. Optical coherence tomography was
employed to measure the resulting penetration depth and col-
orimetric analysis to investigate the associated colour change
of the pressure-indicating sensor film.
Results Microneedle insertion was achieved in vitro at three
different forces, demonstrating the colour change of the
pressure-indicating sensor film upon application of increasing
pressure. When self-applied in vivo, there was no significant
difference in the microneedle penetration depth resulting
from each type of array, with a mean depth of 237 μm record-
ed. When the pressure-indicating sensor film was present, a
colour change occurred upon each application, providing ev-
idence of insertion.
Conclusions For the first time, this study shows how the in-
corporation of a simple, low-cost pressure-indicating sensor
film can indicate microneedle insertion in vitro and in vivo, pro-
viding visual feedback to assure the user of correct application.
Such a strategy may enhance usability of a microneedle device
and, hence, assist in the future translation of the technology to
widespread clinical use.
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INTRODUCTION
Microneedles (MNs) are one of the most promising innova-
tions in drug delivery, with great potential to yield tangible
benefits for both patients and industry in the coming years.
Since the first report of MN technology in the literature (1), a
variety of manufacturing and drug delivery strategies have
been described (2). The focus of the current study is on
hydrogel-forming MNs, which swell on response to skin inter-
stitial fluid, stimulating drug permeation from an attached
reservoir. As the arrays are prepared from well-characterised
biocompatible polymers, with the device sterility and
bioburden considered, there is increasing evidence of what
appears to be a convincing safety record for the hydrogel
platform (3). This integrated system has been shown to deliver
a range of molecules of varying molecular weight, from small
molecules, such as metronidazole and ibuprofen, to larger
molecules, such as insulin and bovine serum albumin (4,5).
Having therefore demonstrated their promise in transdermal
drug delivery, the next stage is to translate this success into
patient outcomes, which will require consideration of MN use
from the end-users’ perspective.
A notable benefit of MNs, compared to a conventional
needle and syringe delivery system, is the opportunity for
self-application, with no requirement for healthcare profes-
sional intervention (6). To ensure MN arrays can be easily
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self-applied by all types of patients, the usability and accept-
ability of any final product must be carefully considered.
Knowledge of these intrinsically linked concepts can only be
gained through engagement with potential end-users, ideally
at the developmental stage. We have previously investigated
the self-application of hydrogel-forming MN arrays, with the
use of a patient information leaflet and pharmacist counselling
for participant instruction (7). Although unanimously success-
ful in MN insertion, following MN self-application, 80% of
the participants reported that they were unsure if they had
applied enough pressure to successfully insert the MNs.
Interestingly, the same point has been raised in other studies,
designed to explore theoretical views and opinions on MN
technology (8–11). In these cases, the willingness of the public
to self-apply MN arrays was highlighted but, simultaneously,
an uncertainty regarding how they would assess their perfor-
mance, noting this as important for personal assurance of drug
delivery. It was, therefore, hypothesised that potential end-
users would prefer the inclusion of a feedback mechanism in
a MN delivery system, in order to provide confirmation that
the MN array has been used appropriately. As an example, a
recent study reported the use of a snap-based device for MN
application, designed to provide audible feedback to the user
upon MN insertion, for the purposes of influenza self-
vaccination (6). The use of this response mechanism increased
skin staining, used as a measure of MN insertion, from 90 to
96% on the first attempt, when compared to MN application
with no feedback device. In this case, however, the method of
feedback, i.e. the snapping noise, was built into the applicator
device and not the array itself. Considering application of a
MN array by hand, with no device to assist, the method of
feedback will need to be incorporated into the patch design, in
order to create a product with similar features to a conven-
tional transdermal patch. As the contentious issue is the force
to be applied, it follows that the ideal response directly relates
to this parameter. The correlation between force and
hydrogel-forming MN insertion has already been established
(12) and, as pressure is defined as force per unit area, the
pressure applied would be a suitable parameter to monitor
for insertion. In the present study, a low-cost pressure-indicat-
ing sensor film (PISF), Pressurex-micro® Green was chosen
for investigation as a method to provide feedback on MN
insertion. Consisting of a micro-encapsulated colour-forming
material and a colour developing material, a red impression is
formed following the application of a minimum pressure of
18.6 Ncm−2 between two contacting, mating or impacting
surfaces. Microscopic pigmented particles adhered to the do-
nor substrate are attracted to the chemically surface-treated
receiver sheet where, upon application of pressure and sepa-
ration of the two layers, micro-shear forces compel the parti-
cles to dislodge the pigment, leaving an impression. Designed
with low contact pressures in mind, the colour intensity of the
resulting image indicates the relative amount of pressure
applied to it. To this end, the greater the pressure exerted
on the film, the darker the intensity colour produced on the
donor film. The two contacting, mating or impacting surfaces
in this case refer to the MN array and the thumb used for
application. By attaching such a film to the reverse of the
MN array, upon application of pressure by the thumb, a col-
our change should occur, qualitatively highlighting the force
employed. Previous work has shown that a force of 11.0 N is
sufficient to apply aMN array of 1 cm2 (13), although a degree
of MN penetration was demonstrated to occur from forces as
low as 4.4 N/array. A minimum pressure requirement of 18.6
Ncm−2 for a response has been chosen to ensure an appropri-
ate depth of MN insertion, while also providing an appropri-
ate margin of safety, in order to guarantee MN insertion. The
current study, therefore, aims to assess the combination of a
PISF with hydrogel-forming MNs, as an indicator of pressure
application and, hence, successful insertion, using optical co-
herence tomography (OCT) as a tool to confirm penetration.
MATERIALS AND METHODS
Chemicals
Gantrez® AN-139, a copolymer of methyl vinyl ether and
m a l e i c a n h y d r i d e ( PMVE /MA , m o l e c u l a r
weight = 1,080,000) was a gift from Ashland, Kidderminster,
UK. Poly(ethylene glycol) (PEG, molecular weight 10,000 Da)
was purchased from Sigma-Aldrich, Steinheim, Germany.
Millipore water was used throughout the study, while all other
chemicals used were of analytical reagent grade. Moisture-
impermeable, heat-sealable poly(ester) foil was purchased
from Transparent Film Products Ltd., Newtownards, UK.
Pressurex-micro® Green tactile pressure-indicating sensor
film was purchased from Sensor Products Inc., Madison,
New Jersey, USA. Elastoplast® Invisible Protection plasters
were obtained from Beiersdorf, Hamburg, Germany.
Fabrication of Hydrogel-Forming MN Arrays
A Gantrez® AN-139 stock solution was prepared by adding
the required mass of Gantrez® AN-139 to ice-cold deionised
water, followed by stirring and heating at 95°C until a clear
gel was obtained, due to hydrolysis of the anhydride form of
the copolymer to the corresponding acid (14). Upon cooling,
the gel was readjusted to the final concentration by addition of
an appropriate amount of deionised water. MN arrays were
then prepared from aqueous blends containing 15% w/w
Gantrez® AN-139 and 7.5% w/w PEG 10,000 as previously
described (5). The blend (500 mg) was poured into laser-
engineered silicone micromoulds composed of 361 (19 × 19)
needles perpendicular to the base and of conical shape. The
needles were each 600 μm high, with base width of 300 μm
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and 50 μm interspacing, arranged on an area of 0.49 cm2,
with a MN-free border giving a final array area of 1.0 cm2.
The filled moulds were centrifuged for 15 min at 2205 g and
dried at ambient temperature for 48 h.MNs were cross-linked
(esterification reaction) by heating at 80°C for 24 h and the
sidewalls formed by the moulding process removed using a
heated blade. Each MN array was affixed to an Elastoplast®
Invisible Protection plaster for application purposes. A PISF
(25 × 40 mm) was then attached using double-sided adhesive
tape (3M, Carrickmines, Ireland), to the reverse of the plaster.
Control MN arrays did not have the addition of the PISF,
consisting solely of the MN array and the plaster. Once as-
sembled, each MN patch was individually packaged using
moisture-impermeable heat-sealable poly(ester) foil and stored
in the laboratory under ambient conditions until required.
Pilot In Vitro Insertion Studies
Initial investigations were conducted using excised neonatal
porcine skin, previously described as a suitable model for hu-
man skin (15), and a TA.XT-Plus Texture Analyser (Stable
Microsystems, Haslemere, UK) for insertion of the MN and
PISF combination. Full thickness neonatal porcine skin was
obtained from stillborn piglets and excised <24.0 h after birth.
Full thickness skin (~0.5 mm) was then stored in aluminium
foil at −20.0°C until further use. Two sections of skin were
placed together, with the dermal sides in contact, such that the
stratum corneum surface was exposed on each side, resulting in a
total skin thickness of approximately 1 mm, ensuring sufficient
depth and support for MN insertion. MN arrays with PISF
attached were gently placed on top of the neonatal porcine
skin and this set-up was positioned under the probe of the
Texture Analyser, the contacting surface of which had an area
of 1 cm2. MN insertion was performed using three forces,
20 N, 30 N and 50 N, each held for 30 s. The pre-test and
post-test speeds were both set at 0.5 m/s and the trigger force
at 0.049 N. Inserted MN arrays were viewed in situ using an
EXT1301 VivoSight® OCT microscope and the resultant
2D images analysed using the imaging software, ImageJ®
(National Institute of Health, Maryland, USA). The swept-
source Fourier domain OCT system has a laser centre wave-
length of 1,305 ± 15 nm, facilitating real-time high resolution
imaging of the upper skin layers (<7.5 μm lateral and < 10 μm
vertical resolution). The scale of the image files obtained was
1.0 pixel = 4.2 μm, thus allowing accurate measurements of
the depth of MN penetration. For each insertion, data was
presented as means (± S.D.) of 10 replicate measurements of
individual MN penetration depth, where the measured MNs
were selected at random from the 361 penetrating MNs in
each array. Following each insertion, the receiver layer of
the PISF was removed and subjected to colorimetric analysis.
The same set-up was followed for manual application, with
insertion of the MNs into the excised skin performed by the
researcher (SON) using thumb pressure, in place of the
Texture Analyser.
Volunteer Recruitment
A detailed protocol was written for the human insertion study
and ethical approval from the School of Pharmacy Ethics
committee was granted prior to study commencement.
Twenty healthy volunteers (ten females and ten males) were
recruited from the final year undergraduate pharmacy popu-
lation at the School of Pharmacy, Queen’s University of
Belfast, via an email circular. Students who had previous ex-
perience of MN research or any pre-existing skin conditions
were excluded from the study. All volunteers were fully briefed
on the study and provided informed consent before proceed-
ing. For 24 h prior to the study, subjects were asked not to use
any cosmetic products on their ventral forearm.
Volunteer Application Protocol
Before beginning the experiment, subjects were asked to rest
in the controlled environment of the study room for 15min, in
order to acclimatise to the experimental conditions of 20°C
and a relative humidity of 45 ± 5%. During this time, they
were asked to read the study information sheet and to com-
plete the consent form. Each subject applied twoMNarrays in
total. One MN array had the PISF included in the patch and
the other did not, with the order of application of the twoMN
arrays varied equally between the subjects. Two areas were
marked on the ventral forearm of the subjects (~1.5 cm2) and
numbered 1 and 2. These areas were then cleansed with an
antiseptic wipe. The subject was presented with the first MN
package, and asked to apply the array to the area labelled
number 1 on their ventral forearm. Instruction on application
was provided in the form of a patient information leaflet and
counselling by the researcher (EMA). This strategy was in-
formed by previous research (7) and adapted for this particu-
lar study to account for the incorporation of the PISF in the
MN array. In brief, the MN package was opened and after
carefully peeling off the protective backing of the plaster, the
MN patch was applied to the ventral forearm. The subjects
were then instructed to apply firm pressure to the reverse of
the MN patch using their thumb for 30 s, ensuring the pres-
sure was applied downwards, in the direction of the skin. If the
PISF was present, the subjects were able to observe the colour
change in response to the pressure applied, as shown in Fig. 1.
The PISF layer, if present, was then removed for further anal-
ysis. Whilst inserted in the forearm, OCTwas used to visualise
the MNs in situ for determination of penetration depth. A
VivoSight® high-resolution OCT Scanner with a lightweight
and manoeuvrable handheld probe (Michelson Diagnostics
Ltd., Kent, UK) was used for this purpose. The resultant 2D
images from OCT scans were analysed as detailed for the
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insertion into excised porcine skin, with 10 replicate measure-
ments of individual MN penetration depth recorded. The
subject was then able to remove the MN array from their
arm. The second MN application was performed following
the same procedure, with the array being applied in this case
to the location on the arm labelled number 2.
Colorimetric Analysis
The receiver layers of the PISF from all MN applications,
both in vitro and in vivo, were retained and scanned to produce
digital images. The scanned image of each individual receiver
layer was then analysed using the Interactive 3D Surface Plot
tool from ImageJ® software. This tool establishes an arbitrary
scale related to the colour intensity, with the varying degrees
of colour indicating the pressure, rather than a specific value.
The surface plots generated are 3D, where the X- and Y-axes
correspond to the area of the film and the Z-axis indicates
colour intensity, providing a visual interpretation of the pres-
sure distribution over the 1.5 cm2 area of the film. Elevated
peaks, on the 3D plot, indicate that a greater pressure was
applied to that area.
Questionnaire
In order to investigate the views and opinions of the volunteers
regarding MNs, a short, structured questionnaire was devel-
oped. The patient satisfaction and preference questionnaire
(PASAPQ), which considers performance, convenience, pref-
erence and willingness to continue, was consulted to assist in
producing the questionnaire for this study (16). The question-
naire used the Likert Scale (strongly negative – strongly posi-
tive), to assess the degree of agreement with a number of
statements regarding the insertion process and their overall
perception of MN technology. Volunteers were also asked to
state their preference (if any) for the MN array, with the PISF
or without. Once designed, the questionnaire was piloted with
researchers in the School of Pharmacy, who were also regis-
tered pharmacists, to ensure clarity of questions and ease of
completion. All subjects were then asked to complete this
questionnaire at the end of the study, following MN
application.
Statistical Analysis
Where appropriate, data was analysed using a t-test or a One-
Way Analysis of Variance (ANOVA) with post-hoc comparison
performed using Tukey’s HSD test. In all cases, p< 0.05 de-
noted significance.
RESULTS
Pilot In Vitro Insertion Studies
The penetration depths of MNs, with attached PISF, inserted
into excised neonatal porcine skin using three different forces
as applied by the Texture Analyser are displayed in Fig. 2. For
comparative purposes, the application of a MN array into the
porcine skin was also completed using thumb pressure, as
applied by the researcher (SON). The penetration depth de-
creased as the force of application was increased, contrary to
what may be predicted. However, there was no significant
difference overall in the penetration depths produced by
20 N, 30 N, 50 N or manual application (p= 0.20). The re-
ceiver layers of the PISF were retained after each application
into the neonatal porcine skin at the varying forces, scanned
and subjected to colorimetric analyses. Table I includes one
representative example of the scanned receiver layer and in-
teractive surface plot 3D image generated for each force
employed for MN insertion into porcine skin. As would be
expected from the specifications of the PISF, a general trend
can be established that, the higher the force, the greater the
transfer of red colour from the donor layer to the receiver
layer. The areas of the film subjected to higher pressures,
revealed a darker impression of colour in the receiver layer,
supported by an increase in the peak heights on the surface
plot graph. It follows, therefore, that as the force increases, the
predominant colours of the surface plots relate to the upper
end of the arbitrary scale. It can be seen that the distribution of
Fig. 1 Images showing the
application of thumb pressure by the
subject to the MN patch on their
ventral forearm (a) and the resulting
colour change of the PISF (b).
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the red colour is not uniform when the Texture Analyser
probe is used for application, with darker red areas, due to
the sides of the MN array, distinguishable in all cases. When
the force was applied manually, however, a difference in the
pattern of colour formed on the receiver layer was noticeable,
with a more uniform colour distribution observed.
Insertion by Human Subjects
Twenty healthy volunteers (10 male and 10 female) aged be-
tween 21 and 23 years old completed the study. MN applica-
tion was well-tolerated by all subjects and no adverse reactions
were noted. All subjects were able to successfully self-apply
MN arrays, with penetration of the stratum corneum confirmed
in each case byOCT. Penetration depth was measured for the
insertion of each MN array, both with and without the PISF
incorporated (Table II). There was no significant difference in
the penetration depth (p= 0.17) obtained with each MN ar-
ray, as self-applied by the subjects, regardless of whether or
not the PISF was included. Colorimetric analyses revealed
uniform transfer of the red colour from the donor to the
Fig. 2 MN penetration depth in excised neonatal porcine skin applied using
the Texture Analyser at varying forces and manual thumb pressure (Means
± S.D., n=5).
Table I Mean Penetration Depths (n=5) and Representative Images of the Receiver Layer of the PISF and the Interactive 3D Surface Plot Generated,
Following MN Insertion into Excised Neonatal Porcine Skin Using the Texture Analyser at 20 N, 30 N, 50 N and Manual Thumb Application
Force MN penetration depth (µm) Receiver layer of 
PISF
Interactive 3D 
surface plot
20 N 185.8 ± 47.7
30 N 173.2 ± 52.5
50 N 132.0 ± 11.2
Manual 153.8 ± 34.9
Pressure-Indicating Sensor Film for Microneedle Application
receiver layer, resulting in relatively even 3D surface plots,
with greater consistency of colour over the full area of the film
than observed in the in vitro tests. Table III includes the pen-
etration depth, alongside the scanned receiver layer and 3D
surface plot generated for three subjects, upon MN insertion,
as examples of the images obtained from each participant.
Questionnaire
The responses to the questionnaire that was completed by all
participants post-application are summarised in Table IV. As
summative questions, subjects were asked their opinion on
MN technology in general and whether they had a preference
for the MN array applied in combination with a PISF or
without. All were positive or strongly positive about MN
technology and, in total, 75% expressed a preference for the
MN array with the PISF incorporated, as displayed in Fig. 3.
DISCUSSION
There are a number of factors considered central to the po-
tential success of MNs as a commercially available pharma-
ceutical product, including their ability to perform as de-
signed, their ability to be used correctly (with reproducible
insertion) and, also, their acceptance by both patients and
healthcare professionals (17). Initial exploration of the views
and opinions regardingMNs, for both drug delivery andmon-
itoring purposes, have yielded positive results, with the major-
ity recognising significant advantages to the use of the plat-
form (8–11). Encouragingly, people have expressed their will-
ingness to self-apply MNs, without the intervention of a
healthcare professional, indeed, highlighting this option as
one of the potential benefits. Concerns have, however, been
noted regarding the uncertainty which may be associated with
MN use, in terms of understanding that it has been correctly
applied, particularly associated with the force required for
Table II MN Penetration Depth when Self-Applied in Human Subjects,
with and Without the Incorporation of a PISF (Means± S.D., n=10)
MN penetration depth (μm)
With PISF 245.2± 65.8
Without PISF 228.1± 53.7
Table III Mean Penetration Depths and Representative Images of the Receiver Layer of the PISF and the Interactive 3D Surface Plot Generated for Three
Volunteers, Following Self-Application of MN Arrays into the Ventral Forearm
Volunteer
number
MN penetration depth (µm) Receiver layer of 
PISF
Interactive 3D 
surface plot
4 247.4 ± 32.5 μm
10 273.5 ± 33.9 μm
16 223.5 ± 17.3 μm
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MN insertion. One option to address this is the use of an
applicator device for insertion, providing a calibrated force
for each application. However, such an approach does not
necessarily provide reassurance to the user and is likely to
result in a more complex product, which may inhibit patient
adherence (17). Another, more promising, proposed solution
is the incorporation of a method of feedback into aMN patch,
designed to respond and inform the user of successful MN
application, thus ensuring drug delivery or equally, sample
collection, if being used for monitoring purposes. The use of
a method of feedback to ensure reproducible insertion is pref-
erable to an applicator, in order to mimic the conventional
transdermal patches already on the market and capitalise on
preconceived positive beliefs relating to such existing dosage
forms. As proven by a previous study conducted by Donnelly
et al. (7), feedback such as this is not necessary for appropriate
insertion of MNs, reporting reproducible self-application of
hydrogel-formingMNs, assisted by a patient information leaf-
let and pharmacist counselling. However, input from the end-
user has been previously observed to be closely related to the
acceptance of a pharmaceutical product once commercially
available, with evidence linking the oversight of potential pa-
tient perspectives to the failure or poor uptake of many health
innovations, including drug delivery devices (18). It is, there-
fore, important to acknowledge and act upon potential issues
such as this, to assist in a smooth transition to clinic, enabling
the end-user to derive the greatest benefit from the final MN
product. Indeed, it is also thought it may be necessary to
include some form of ‘dosing indicator,’ similar to that de-
scribed, to gain acceptance from regulatory authorities (e.g.,
Food andDrug Administration, EuropeanMedicines Agency)
(17). This study, therefore, investigated the ability of a PISF to
act as a feedback mechanism, when combined with a MN
array, specifically considering the colour change that occurred
and the resulting needle penetration depth.
The use of the Texture Analyser for insertion of MNs com-
bined with a PISF into excised neonatal porcine skin was
designed as an in vitro precursor to in vivo application in human
subjects. Three forces were chosen to demonstrate the poten-
tial difference in colour change occurring upon the applica-
tion of increasing force and any related impact on penetration
depth. The PISF used stipulates a minimum pressure of 18.6
Ncm−2 to cause colour transfer, hence 20 N was the lowest
force chosen for investigation, applied using a 1 cm2 probe. A
change in colour from white to red was noticeable on all
receiver layers following application of force by the texture
analyser. In each case, needle insertion into the porcine skin
was also achieved, with mean penetration depths as detailed in
Table I. This demonstrates the ability of the PISF to success-
fully indicate the application of force to the MN array and,
hence, the insertion of needles into the skin. There was, how-
ever, incomplete contact between the Texture Analyser and
the MN array, due to the rigidity of the metal probe and the
potentially uneven surface of the skin, which was reflected in
the scattered colour pattern produced. In contrast, the use of
thumb pressure for MN insertion into excised neonatal por-
cine skin created a more uniform distribution of colour, at a
force estimated to be equivalent to approximately 20 N, based
on findings reported by Larreñata et al. (12). This difference in
response is likely due to the ability of the thumb to conform
around theMN array and the skin below, thereby distributing
the pressure over the full area of the array. Such a factor is
Table IV Human Subjects’ Rating
of MNs and the Application
Procedure, According to a Likert
Scale (n=10)
Scenario Very satisfied Satisfied Neither satisfied or
dissatisfied
Dissatisfied Very
dissatisfied
Application procedure 14 6 0 0 0
Applied dose would enter the body 9 8 3 0 0
Works reliably 9 8 3 0 0
Ease of application 14 5 0 1 0
Counselling & patient information
leaflet
18 1 1 0 0
Fig. 3 Subjects’ opinions regarding
MN technology in general (a) and
preference for MN arrays with or
without PISF (b), following MN
application.
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likely to be of greater importance in vivo, considering the con-
tours of the body. Despite the variability observed in the col-
orimetric analyses of the different in vitro applications, there
was no significant difference in the penetration depths of each
MN array applied at different forces (p= 0.20). It can, there-
fore, not be established from the in vitro test in this case, if the
application of a greater force and, hence, higher pressure will
result in deeper MN penetration. This is contrary to previous
reports that have found a significant enhancement in the
depth of penetration into skin upon increase of the force used
for application (13). The MNs used in the present study, how-
ever, were of a different geometry to that described (19 × 19 in
comparison to 11 × 11) and, therefore, display different inser-
tion properties. Further to this, the forces employed for appli-
cation were significantly higher in the current study. At great-
er forces, less differentiation between penetration depths may
be expected, due to a ‘bed of nails’ effect, limiting needle
penetration (19), a phenomenon particularly of note with the
high needle density employed in this study.
Human subjects applied two MN arrays to themselves
as part of this study, one array with a PISF incorporated
and one without, to act as a comparator. The aim herein
was simply to verify if application in vivo using thumb
pressure was sufficient to provoke a colour change of the
PISF, thereby providing a suitable level of feedback for
the user, whilst also confirming MN insertion. All subjects
were able to successfully self-apply the MN arrays, follow-
ing appropriate instruction, in line with previous studies
investigating the ability of human subjects to use MNs
(6,7). Using OCT, a mean penetration depth of 237 μm
was recorded, similar to previously reported values for
this particular type of MN array (20). There was no sig-
nificant difference between the penetration depths record-
ed from each of the two types of MN array i.e. with and
without the PISF, demonstrating that the addition of a
PISF did not affect the performance of the subject or
indeed, the insertion of the needles. In all cases, when
the PISF was incorporated, there was a colour change
following application of thumb pressure to the array, ver-
ifying that the force applied by the human subjects was
enough to cause the transfer of colour from the donor to
the receiver layer of the film. Considered in context, with
the OCT data discussed previously, it can then also be
stated that sufficient force was applied to cause needle
penetration into the skin. Although the exact force ap-
plied by each subject was unknown, due to the response,
it can be assumed that the resultant pressure was above
18.6 Ncm−2, the threshold for a colour change. As a vi-
sual aid for the user, the feedback mechanism, therefore,
fulfilled its purpose of confirming the application of suffi-
cient force for MN insertion. The participants reinforced
the success of the PISF, with 75% expressing a preference
for the combination of the MN array with the PISF
incorporated, following application of MNs with and
without it. This is in agreement with previous studies,
which have highlighted the desire of both potential end-
users and prescribers to receive some form of feedback
upon MN application, as an assurance of correct use
(8–11). This outcome provides important information for
the translation of MN technology from the laboratory to a
viable commercial product. The addition of a PISF is
likely to assist in the roll-out of a MN product to a main-
stream market, by enhancing patient acceptability and
maximising ease of use. Indeed, in certain clinical situa-
tions, the use of a PISF would be particularly useful to
confirm MN insertion. For example, the delivery of high
doses of low potency drugs using polymeric MNs has re-
cently been realised, proposing a patch size of up to
30 cm2 to achieve therapeutic levels of a low molecular
weight drug in human (4,21,22). It is envisaged that such
a larger patch size would be self-applied using two or
three fingers, rather than the thumb, as described for
1 cm2 arrays. In these cases, a method of feedback, such
as a colour change, upon MN insertion would likely be a
vital component of the patch to confirm pressure applica-
tion across the complete surface of the MN array. A PISF
is, therefore, likely to have great impact in the future
translation of MN research to commercial products, in
clinical use. In combination with standard measures, such
as a patient information leaflet and pharmacist counsel-
ling, a method of feedback may assist people in applying
MN arrays safely and effectively, providing further evi-
dence for the feasibility of MN self-application.
CONCLUSION
For the first time, this study shows how the incorporation of a
simple, low-cost PISF can ensure MN insertion in human
subjects, providing a level of assurance regarding appropriate
use. A colour change occurred in all cases, alongside MN
penetration, demonstrating that a PISF can provide visual
feedback to the user upon MN application. Further to this,
three quarters of the subjects involved declared a preference
for the MN and PISF combination, following application of
both it and a control array. This study, therefore, provides
convincing evidence as to the use of a feedback mechanism,
specifically a PISF, for confirmation of successful MN self-
application.
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